Author(s): Azoulay D, Vachapova V, Shihman B, Miler A, Karni A
Abstract Share this page
Abstract Neuronal growth factors may exert a neuroprotective effect in multiple sclerosis (MS). We found reduced levels of brain-derived neurotrophic factors (BDNF) in the serum and CSF of relapsing-remitting MS patients, which was reversed by therapy with glatiramer acetate. BDNF may play a protective role in MS, and immunomodulation therapy, such as with glatiramer acetate, may enhance the action this mechanism.
This article was published in J Neuroimmunol
and referenced in Journal of Addiction Research & Therapy